Latest Research News
Improving the Detection and Management of Kidney Health in Primary Care
Chronic kidney disease (CKD) is a major cause of morbidity and mortality, contributing to approximately 20,000 deaths in 2021 in Australia. Importantly, progression of CKD can be substantially reduced if it is detected and treated early. Here we present the perspectives of a general practitioner (primary care physician), a nephrologist and a patient advocate on how the diagnosis and management of CKD in primary care could be improved. Early detection and treatment of CKD are impeded by limited patient awareness and knowledge, communication challenges between patients and doctors, and psychosocial issues, with these factors also interacting with, and exacerbating, each other.
Diabetic kidney disease: strategies for holistic management
Diabetic Kidney Disease (DKD) continues to be a major problem in Australia despite new treatment options being available. This paper published in Endocrinology today discusses how early diagnosis together with medications form part of a holistic management plan for people with diabetes and CKD and not only improves health outcomes but also slows the progression of the disease.
Diabetic kidney disease: a new era in therapeutic management
Chronic kidney disease associated with diabetes is the biggest cause of kidney failure in Australia. A new article published in medicine today and co-authored by Kidney Health Australia board chair, Professor Carol Pollock, discusses new medicines for people with diabetes that can also help protect the kidney.
Meet the Newest Acronym in Primary Care: CKM
The advisory, published recently in Circulation, explores the links between CKD, CVD and diabetes and classifying a new ‘CKM’ syndrome.
New research offers hope of revolutionising approaches to monitoring kidney health
In a study, published in Nature Communications, researchers from the University of Edinburgh have shown that specialised eye scans using an imaging technology called optical coherence tomography (OCT) could be used to monitor kidney disease progression.
Major kidney trial stopped 1 year early due to overwhelmingly positive results
Major kidney study 'FLOW' stopped 1 year early due to overwhelmingly positive results. The study is evaluating the affect of medication Semaglutide, commonly known as Ozempic, on the progression of kidney disease, results of the study are expected to be published early in 2024.
New medical condition bridges gap between obesity, diabetes and heart disease
The American Heart Association has identified a new medical condition that links heart disease to several other health conditions, including kidney disease, diabetes and obesity — offering new guidance in testing those as young as 30 for the chronic ailments.
New drug allowed Ondie to give Rob her kidney
Kidney Health Australia supported Hansa biopharma in the registration process and also put in two submissions to MSAC to support the approval of the drug Imlifidase for use in Australia. It's great to see the outcome of these new treatments!
Please note: this article is behind a paywall.